Zepbound News — every source, one live feed
Track Zepbound news in real time — Lilly's obesity-branded tirzepatide leading the weight-loss market. fllwup^ collects the latest Zepbound headlines from every major source into one live feed — free, no account, no algorithm. Coverage aggregated from BBC, Reuters, AP, NYT, TechCrunch, Al Jazeera, and 200+ other outlets.
Latest Zepbound headlines
- Researchers looking into whether GLP-1 drugs can help slow aging — ABC News - Breaking News, Latest News and Videos
- Lilly's Zepbound remains physicians' favorite, even as oral obesity launches alter landscape — Fierce Pharma
- How To Get Zepbound: Eligibility Criteria And Where To Buy — Forbes
- How to Use LillyDirect for Zepbound and Foundayo Prescriptions — Health US News
- Zepbound helped me lose 18% of my body weight. I wish I didn't feel the need to apologize for it. — Business Insider
- Understanding the Science Behind Zepbound Weight Loss — Guttmacher Institute
- Foundayo and Zepbound now covered for millions of Americans — Eli Lilly and Company
- The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patients — Science Daily
- How Does LLY's Q2 GLP-1 Portfolio Performance Stack Up Against NVO's? — TradingView
- Eli Lilly Sues Mounjaro, Zepbound Generics as GLP-1 Disputes Multiply — Law.com
Follow Zepbound live on fllwup^ — or browse all topics.
More Health & Medicine: browse the category. Compare: fllwup^ vs Flipboard · vs Feedly · vs Google News · vs Apple News.